GO EUROPE
& MENA
ONESTOP AGENCY
Large markets, clear strategy: Europe and MENA as growth drivers
The European Union, with its largely harmonized standards, is the world's largest economic area. According to recent data, the EU alone accounts for around 15% of global gross domestic product (GDP), while Europe as a whole contributes an estimated 24–25% to global economic output. This gives the continent enormous potential, but it is also characterized by highly regulated healthcare systems and stringent requirements for evidence, quality, and transparency. In this context, the MENA region is gaining additional strategic importance: it serves many companies as a market and testing environment, allowing them to successfully position products and gain real-world market experience while approval processes are still underway in individual European countries – such as Germany. This allows companies to effectively bridge the gap until final approval, build market acceptance, and generate reliable data. At the same time, the European Union, with its harmonized standards, represents a clear target market for companies with a forward-looking and integrated market entry strategy.
The same thing isn’t necessarily identical.
The OneStop Agency translates the sometimes complex regulatory and market-specific European requirements into concrete, actionable strategies, particularly for Chinese companies and products targeting the European market. We not only guide you through the formal approval process in Europe and the MENA region, but also support targeted market preparation: from positioning your product or service to physicians, pharmacists, and patients, to adapting communication and evidence strategies, and selecting suitable distribution channels and local partners. This is how regulatory compliance translates into sustainable market success.
We integrate Traditional Chinese Medicine (TCM) and Western medicine.
A particular focus of our expertise lies in the cultural and medical translation of Traditional Chinese Medicine (TCM): We do not present TCM concepts in isolation, but rather translate them into indications, mechanisms of action, and benefits that are understandable to Westerners. At the same time, we preserve the authenticity of traditional medicine. We have nearly a decade of experience in this field in Europe and work closely and collaboratively with renowned partners such as Charité Berlin and the German-Chinese Society for Medicine.
Germany – the gold standard and door opener in Europe
Germany has long been known as the "pharmacy of the world"—and for good reason: High regulatory requirements, strict quality standards, and a deep-rooted trust in pharmaceutical research continue to make it a benchmark for innovation and reliability. Particularly in phytotherapy, one of Europe's oldest medical traditions, Germany is a leader and boasts one of the longest and most widespread uses of herbal medicines on the continent. Around two-thirds of Germans have already tried natural remedies such as herbal medicines and appreciate their role in healthcare, with herbal preparations continuing to play a significant role in the market.
It is no coincidence, then, that a company like TaslyPharma, with its subsidiary Tasly Germany, has chosen to headquarter here in the heart of Europe: Germany stands for trust, quality, and a pharmaceutical ecosystem that not only permits but actively supports product innovation. Success in the German market is considered a door opener – not only for the entire EU single market but also for the MENA regions. Those who successfully enter the market here benefit from a high reputation, a strong regulatory foundation, and a strategic position that paves the way for sustainable growth and international recognition. Germany is more than just a location – it is a seal of quality for long-term market success.
